The cytotoxic activities of cardiac glycosides from Streptocaulon juventas and the structure-activity relationships.

A series of cardiac glycosides were isolated and identified from the anti-tumor fraction of the root of Streptocaulon juventas in previous studies. In the present research, the cytotoxic activities of the 43 cardiac glycosides on three cell lines, human lung A549 adenocarcinoma cell, large cell lung cancer NCI-H460 cell and normal human fetal lung fibroblast MRC-5 cell, were evaluated in vitro. Most of the tested compounds showed potent inhibitory activities toward the three cell lines. Then, the structure-activity relationships were discussed in detail. It was indicated that hydroxyl and acetyl groups at C-16 increased the activity, whereas hydroxyl group at C-1 and C-5 can both increase and decrease the activity. Two glucosyl groups which were connected by C1'→C6' showed better inhibitory activity against cancer cell lines, while the C1'→C4' connection showed stronger inhibitory activity against the normal cell line. Also, this is the first report that the activities of these compounds exhibited different variation trends between A549 and NCI-H460 cell lines, which indicated that these compounds could selectively inhibit the cell growth. The results would lay a foundation for further research on new anti-tumor drug development.
AuthorsRui Xue, Na Han, Chun Ye, Lihui Wang, Jingyu Yang, Yu Wang, Jun Yin
JournalFitoterapia (Fitoterapia) Vol. 98 Pg. 228-33 (Oct 2014) ISSN: 1873-6971 [Electronic] Netherlands
PMID25128424 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Cardiac Glycosides
  • Antineoplastic Agents (chemistry, pharmacology)
  • Apocynaceae (chemistry)
  • Cardiac Glycosides (chemistry, pharmacology)
  • Cell Line, Tumor
  • Humans
  • Molecular Structure
  • Plant Roots (chemistry)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: